Patient/caregiver influences for declining participation in supportive oncology trials

Journal of Supportive Oncology

Volumn 6, Issue 4, 2008, Pages 168-174

  Buss, Mary K ^a,b   DuBenske, Lori L ^a,b   Dinauer, Susan ^a,b   Gustafson, David H ^a,b   McTavish, Fiona ^a,b   Cleary, James F ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b University of Wisconsin Madison   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; ARTICLE; BREAST CANCER; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RESEARCH; CAREGIVER BURDEN; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN COMPUTER INTERACTION; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; PATIENT ATTITUDE; PATIENT CARE; PATIENT PARTICIPATION; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; STRATEGIC PLANNING;

CAREGIVERS; DECISION MAKING; HUMANS; INTERNET; NEOPLASMS; PATIENT PARTICIPATION; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REFUSAL TO PARTICIPATE; SOCIAL SUPPORT;

EID: 42549157977     PISSN: 15446794     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Gelber RD, Goldhirsch A. Can a clinical trial be the treatment of choice for patients with cancer? J Natl Cancer Inst 1988;80:886-887.
2. Benson AB 3rd, Pregler JP, Bean JA, Rademaker W, Eschler B, Anderson K. Oncologists' reluctance to accrue patients onto clinical trials: an Illinois Cancer Center study. J Clin Oncol 1991;9:2067-2075.
3. Cockburn J, Redman S, Kricker A. Should women take part in clinical trials in breast cancer? Issues and some solutions. J Clin Oncol 1998;16:354-362.
4. Fisher B. On clinical trial participation. J Clin Oncol 1991;9:1927-1930.
5. Jordhoy MS, Kaasa S, Fayers P, Ovreness T, Underland G, Ahlner-Elmqvist M. Challenges in palliative care research:recruitment, attrition and compliance: experience from a randomized controlled trial. Palliat Med 1999;13:299-310.
6. Klabunde CN, Springer BC, Butler B, White MS, Atkins J. Factors influencing enrollment in clinical trials for cancer treatment. South Med J 1999,92:1189-1193.
7. Sawka CA, Pritchard KI. Can improved communication increase patient participation in randomised clinical trials? Eur J Cancer 2001;37:297-329.
8. Ling J, Rees E, Hardy J. What influences participation in clinical trials in palliative care in a cancer centre? Eur J Cancer 2000;36:621-626.
9. Fallowfield L, Ratcliffe D, Souhami R. Clinicians' attitudes to clinical trials of cancer therapy. Eur J Cancer 1997;33:2221-2229.
10. Fallowfield LJ, Jenkins V, Brennan C, Sawtell M, Moynihan C, Souhami RL. Attitudes of patients to randomised clinical trials of cancer therapy. Eur J Cancer 1998;34:1554-1559.
11. Addington-Hall JM, MacDonald LD, Anderson HR, et al. Randomised controlled trial of effects of coordinating care for terminally ill cancer patients. BMJ 1992;305:1317-1322.
12. Henderson M, Addington-Hall JM, Hotopf M. The willingness of palliative care patients to participate in research. J Pain Symptom Manage 2005;29:116-118.
13. Christakis NA, Lamont EB. Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study. BMJ 2000;320:469-472.
14. Steinhauser KE, Clipp EC, Hays JC, et al. Identifying, recruiting, and retaining seriously-ill patients and their caregivers in longitudinal research. Palliat Med 2006;20:745-754.
15. Murphy MR, Escamilla MI, Blackwell PH, et al. Assessment of caregivers' willingness to participate in an intervention research study. Res Nurs Health 2007;30:347-355.
16. Ostroff J, Ross S, Steinglass P, Ronis-Tobin V, Singh B. Interest in and barriers to participation in multiple family groups among head and neck cancer survivors and their primary family caregivers. Fam Process 2004;43:195-208.
17. McMillan SC, Weitzner MA. Methodologic issues in collecting data from debilitated patients with cancer near the end of life. Oncol Nurs Forum 2003;30:123-129.
18. Schrump DS, Altorki NK, Henschke CL, et al. Non-small cell lung cancer. In: De Vita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 7th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2005:793.
19. Vanderwerker LC, Laff RE, Kadan-Lottick NS, McColl S, Prigerson HG. Psychiatric disorders and mental health service use among caregivers of advanced cancer patients. J Clin Oncol 2005;23:6899-6907.
20. Cherlin EJ, Barry CL, Prigerson HG, et al. Bereavement services for family caregivers: how often used, why, and why not. J Palliat Med 2007;10:148-158.
21. Seamark DA, Gilbert J, Lawrence CJ, William S. Are postbereavement research interviews distressing to carers? Lessons learned from palliative care research. Palliat Med 2000;14:55-56.
22. Stroebe M, Stroebe W, Schut H. Bereavement research:methodological issues and ethical concerns. Palliat Med 2003;17:235-240.
23. Huizinga GA, Slejfer DT, van de Wiel HB, van der Graaf WT. Decision-making process in patients before entering phase III cancer clinical trials: a pilot study. Cancer Nurs 1999;22:119-125.
24. Albrecht TL, Franks MM, Ruckdeschel JC. Communication and informed consent. Curr Opin Oncol 2005;17:336-339.
25. Jenkins V, Fallowfield L. Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy. Br J Cancer 2000;82:1783-1788.
26. Albrecht TL, Blanchard C, Ruckdeschel JC, Coovert M, Strongbow R. Strategic physician communication and oncology clinical trials. J Clin Oncol 1999;17:3324-3332.